US Edition
Specialty Drug Dispensing and Manufacturer Fees Now Dominate PBM Revenue Sources
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Former Big Pharma CEO: ‘PBMs Are Not The Bandits’
In case you missed it, a former Big Pharma CEO called the pharmaceutical industry’s attempt to shift the blame game for high prescription drug prices onto pharmacy benefit managers (PBMs) a “weak explanation,” and affirmed the cost-reducing value of PBMs. Speaking with Danish news outlet BØRSEN in a recent interview, Jesper Høiland, former U.S. CEO of Novo Nordisk, said (translated to English from Danish) of Big Pharma pointing a finger at PBMs:…
Specialty Drug Dispensing and Manufacturer Fees Now Dominate PBM Revenue Sources
A recent analysis highlights significant shifts in how […] The post Specialty Drug Dispensing and Manufacturer Fees Now Dominate PBM Revenue Sources first appeared on GeneOnline News. The post Specialty Drug Dispensing and Manufacturer Fees Now Dominate PBM Revenue Sources appeared first on GeneOnline News.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
